Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Gross Profit (2022 - 2025)

Historic Gross Profit for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $90.5 million.

  • Arcutis Biotherapeutics' Gross Profit rose 13064.81% to $90.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.0 million, marking a year-over-year increase of 13021.51%. This contributed to the annual value of $177.4 million for FY2024, which is 22482.1% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Gross Profit is $90.5 million, which was up 13064.81% from $74.0 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Gross Profit registered a high of $90.5 million during Q3 2025, and its lowest value of $456000.0 during Q3 2022.
  • Its 4-year average for Gross Profit is $34.5 million, with a median of $28.8 million in 2023.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Gross Profit soared by 621973.68% in 2023 and then soared by 2311.01% in 2025.
  • Over the past 4 years, Arcutis Biotherapeutics' Gross Profit (Quarter) stood at $2.5 million in 2022, then surged by 355.57% to $11.3 million in 2023, then skyrocketed by 471.41% to $64.5 million in 2024, then surged by 40.46% to $90.5 million in 2025.
  • Its Gross Profit was $90.5 million in Q3 2025, compared to $74.0 million in Q2 2025 and $57.0 million in Q1 2025.